Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China · Delayed Price · Currency is CNY 6.74
+0.05 (0.75%)
Jul 29, 2026, 3:04 PM CST
SHE:002349 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,587 | 6,023 | 6,228 | 7,222 | 9,835 | 9,184 | |
Market Cap Growth | -12.78% | -3.29% | -13.75% | -26.57% | 7.09% | 130.20% |
Enterprise Value | 4,761 | 5,226 | 5,271 | 6,314 | 9,350 | 8,968 |
Last Close Price | 6.74 | 7.17 | 7.47 | 8.56 | 11.56 | 10.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.78 | 27.47 | 29.29 | 29.16 | 46.34 | 57.15 |
Forward PE | - | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 |
PS Ratio | 3.78 | 4.13 | 4.44 | 4.78 | 6.25 | 6.76 |
PB Ratio | 1.73 | 1.91 | 2.11 | 2.58 | 3.75 | 3.57 |
P/TBV Ratio | 2.15 | 2.38 | 2.65 | 3.26 | 4.54 | 4.72 |
P/FCF Ratio | 19.02 | 18.79 | 22.24 | 27.47 | 33.14 | 40.81 |
P/OCF Ratio | 17.69 | 17.67 | 20.03 | 24.79 | 27.44 | 30.06 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.22 | 3.58 | 3.76 | 4.18 | 5.94 | 6.60 |
EV/EBITDA Ratio | 13.21 | 15.09 | 17.11 | 16.49 | 29.27 | 34.78 |
EV/EBIT Ratio | 17.06 | 19.57 | 22.62 | 21.14 | 44.24 | 57.30 |
EV/FCF Ratio | 16.20 | 16.30 | 18.82 | 24.01 | 31.50 | 39.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 |
Debt / EBITDA Ratio | 0.02 | 0.01 | 0.04 | 0.06 | 0.07 | 0.75 |
Debt / FCF Ratio | 0.02 | 0.01 | 0.04 | 0.09 | 0.08 | 0.87 |
Net Debt / Equity Ratio | -0.38 | -0.41 | -0.37 | -0.43 | -0.39 | -0.26 |
Net Debt / EBITDA Ratio | -3.45 | -3.71 | -3.59 | -3.18 | -3.24 | -2.60 |
Net Debt / FCF Ratio | -4.22 | -4.01 | -3.95 | -4.63 | -3.49 | -2.98 |
Asset Turnover | 0.42 | 0.43 | 0.43 | 0.49 | 0.50 | 0.43 |
Inventory Turnover | 2.58 | 2.60 | 2.57 | 2.61 | 2.69 | 2.34 |
Quick Ratio | 4.67 | 4.33 | 4.72 | 4.50 | 3.55 | 2.05 |
Current Ratio | 5.54 | 5.14 | 5.67 | 5.49 | 4.38 | 2.64 |
Return on Equity (ROE) | 8.68% | 8.58% | 8.59% | 10.19% | 8.18% | 5.54% |
Return on Assets (ROA) | 4.98% | 4.86% | 4.49% | 6.00% | 4.23% | 3.08% |
Return on Invested Capital (ROIC) | 12.50% | 12.40% | 11.44% | 15.78% | 10.28% | 6.30% |
Return on Capital Employed (ROCE) | 8.50% | 8.40% | 7.80% | 10.60% | 8.00% | 6.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.99% | 3.64% | 3.41% | 3.43% | 2.16% | 1.75% |
FCF Yield | 5.26% | 5.32% | 4.50% | 3.64% | 3.02% | 2.45% |
Dividend Yield | 1.35% | 1.26% | 1.07% | 1.07% | 0.69% | 0.56% |
Payout Ratio | 29.25% | 29.75% | 35.52% | 26.64% | 25.44% | 27.69% |
Buyback Yield / Dilution | -0.66% | -0.58% | 0.01% | -0.02% | 0.00% | 0.03% |
Total Shareholder Return | 0.68% | 0.68% | 1.08% | 1.05% | 0.70% | 0.59% |